Diane Finegood
Cited by
Cited by
The global obesity pandemic: shaped by global drivers and local environments
BA Swinburn, G Sacks, KD Hall, K McPherson, DT Finegood, ML Moodie, ...
The Lancet 378 (9793), 804-814, 2011
Assessment of Insulin Sensitivity in Vivo
RN Bergman, DT Finegood, M Ader
Endocrine reviews 6 (1), 45-86, 1985
Changing the future of obesity: science, policy, and action
SL Gortmaker, BA Swinburn, D Levy, R Carter, PL Mabry, DT Finegood, ...
The Lancet 378 (9793), 838-847, 2011
A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
RS Legro, D Finegood, A Dunaif
The Journal of Clinical Endocrinology & Metabolism 83 (8), 2694-2698, 1998
Dissemination and implementation research in health: translating science to practice
RC Brownson, GA Colditz, EK Proctor
Oxford University Press, 2017
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
A Dunaif, D Scott, D Finegood, B Quintana, R Whitcomb
The Journal of Clinical Endocrinology & Metabolism 81 (9), 3299-3306, 1996
Grand challenges in chronic non-communicable diseases
AS Daar, PA Singer, DL Persad, SK Pramming, DR Matthews, ...
Nature 450 (7169), 494-496, 2007
Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model
DT Finegood, L Scaglia, S Bonner-Weir
Diabetes 44 (3), 249-256, 1995
Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates
DT Finegood, RN Bergman, M Vranic
Diabetes 36 (8), 914-924, 1987
Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome
A Dunaif, DT Finegood
The Journal of Clinical Endocrinology & Metabolism 81 (3), 942-947, 1996
Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat
L Scaglia, CJ Cahill, DT Finegood, S Bonner-Weir
Endocrinology 138 (4), 1736-1741, 1997
β-Cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death
DT Finegood, MD McArthur, D Kojwang, MJ Thomas, BG Topp, T Leonard, ...
Diabetes 50 (5), 1021-1029, 2001
The need for a complex systems model of evidence for public health
H Rutter, N Savona, K Glonti, J Bibby, S Cummins, DT Finegood, ...
The lancet 390 (10112), 2602-2604, 2017
The evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes
RN Bergman, DT Finegood, SE Kahn
European journal of clinical investigation 32, 35-45, 2002
Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog
G Toffolo, RN Bergman, DT Finegood, CR Bowden, C Cobelli
Diabetes 29 (12), 979-990, 1980
Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?
JD Trudeau, JP Dutz, E Arany, DJ Hill, WE Fieldus, DT Finegood
Diabetes 49 (1), 1-7, 2000
A model of β-cell mass, insulin, and glucose kinetics: pathways to diabetes
B Topp, K Promislow, G Devries, RM Miura, D T FINEGOOD
Journal of theoretical biology 206 (4), 605-619, 2000
Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and β-cell …
JA Pospisilik, SG Stafford, HU Demuth, R Brownsey, W Parkhouse, ...
Diabetes 51 (4), 943-950, 2002
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood
JD Trudeau, C Kelly-Smith, CB Verchere, JF Elliott, JP Dutz, DT Finegood, ...
The Journal of clinical investigation 111 (2), 217-223, 2003
Defects in insulin secretion and action in women with a history of gestational diabetes
EA Ryan, SI Imes, D Liu, R McManus, DT Finegood, KS Polonsky, J Sturis
Diabetes 44 (5), 506-512, 1995
The system can't perform the operation now. Try again later.
Articles 1–20